Darzalex Iv 57894-0505-20
Generic: Daratumumab
- Manufacturer
- Janssen Biotech, Inc.
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 15, 2021
- Listing Expires
- December 31, 2027
- Application
- BLA761036
Need to source Darzalex Iv? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Daratumumab | 100 mg/5mL |
Drug Class
CD38-directed Cytolytic Antibody [EPC]AntibodiesMonoclonal [CS]
Selected Package
57894-0505-20Selected1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-20) / 20 mL in 1 VIAL, SINGLE-DOSE
Other packages for this product(1)
1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE